The invention relates to a liquid, propellant-free pharmaceutical formulation for administration by nebulisation comprising a antimuscarinic drug as active ingredient. The invention also relates to the process for the preparation of the formulation and to its use in the prevention and/or treatment of a wide range of conditions including respiratory disorders.